$2,590.00

RPMI-1788/Cre stable cell line

Catalog number
CL-2344
Description
RPMI-1788/Cre cells are derived from the human B lymphocyte RPMI-1788 cell line by stably integration of a constitutive Cre recombinase stably expression construct. RPMI-1788 cells have been used in cancer research and drug development. RPMI-1788/Cre cells stably express a nuclear localized Cre recombinase under the control of a CMV promoter.

Product Details

Package Size 2 x 10^6 cells
Parental cell line RPMI-1788 cells
Transgenic gene Cre recombinase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2025, FenicsBIO. All rights reserved.